K. Mukantayev, K. Mukanov, and A. Zhylkibayev, “ROLE OF MONOCLONAL ANTIBODIES AGAINST THE PROGRAMMABLE DEATH (PD-1) RECEPTOR OF T-CELLS IN TARGETED THERAPY OF MELANOMA”, Eurasian Journal of Applied Biotechnology, no. 1, Jan. 2018.